BarneyWinni

Mang cloud biocoups near B+1

barneywinni@newsletter.paragraph.com (BarneyWinni) — Wed, 31 May 2023 11:34:48 GMT

The current shareholder, Charba, has continued to invest, with the participation of the Dutch ponds, the Thai Qhua, the In-In-In-In-Integrated Fund and the State of Thailand.

On 15 May, a recent announcement was made by Nanjing Yukio Takasu, Inc. (known as “Red Yunus”, that nearly 100 million yuan renminbi B+ swaps had been completed, co-sponsored by the Dutch ponds, the Gulf of Guinea in Thailand, the Ingion Fund and the State of Thailand Astronomical Fund, with ongoing investments by existing shareholders in Chariba. The fund will simultaneously develop a new generation of EGFR inhibitors H002 in China and the United States for clinical trials in non-small cell pulmonary cancers, while accelerating the development of pipelines and technology based on a unique structural pharmacological platform based on mangroves. Mangune is a clinical phase of small molecular innovation research and development, with structural pharmacology at the core, integrating molecular mocking, chemistry and artificial intelligent (AI). Mange clouds have accumulated unique structural biology data and algorithmic models in several clinical demand-oriented areas, and have set up a number of molecules for drug development and pipelines that cover tumours, rare diseases and other treatments with highly unmet clinical needs. Currently, H002, a company-owned, entirely new molecular drug, is conducting a clinical test study in the Central American region, which is expected to be the best option for the next generation of EGFR-TKI inhibitors. At the same time, the company’s first inclination project on multiple tumours, such as breast cancer, has entered the PCC phase and is expected to declare clinical in 2024.

No new for 39 consecutive days! Report on the latest epidemic situation in Jiangxi

barneywinni@newsletter.paragraph.com (BarneyWinni) — Fri, 08 Apr 2022 21:51:58 GMT

From 0:00 to 24:00 on March 6, 2022, there was no report of new local confirmed cases or new asymptomatic infections in Jiangxi Province. As of 24:00 on March 6, 2022, the province has reported 952 locally confirmed cases, 951 discharged cases and 1 death case.

At 0-24 hours in March 6, 2022, no confirmed case of New Coronavirus pneumonia was imported from Jiangxi province. As of 24:00 on March 6, 2022, the province has reported 7 confirmed cases and associated cases imported from abroad, 7 discharged cases, and no hospitalized confirmed cases imported from abroad.

Jiangxi Provincial Health Commission

March 7, 2022

Guizhou iron tower starts the centralized purchase of simple small switching power supply and other products in 2022

barneywinni@newsletter.paragraph.com (BarneyWinni) — Fri, 18 Mar 2022 11:03:39 GMT

C114 news on March 7 (Nanshan) according to the official news of China’s iron tower, the centralized procurement project of simple small switching power supply and other products and accessories of Guizhou iron tower in 2022 has met the bidding conditions, and now a public bidding is carried out.

This project purchases 2 kinds of simple small switching power supply basic frames, 2 kinds of simple switching power supply basic frames and 10 kinds of related accessories from nine cities and prefectures in the province. The estimated tax included amount is RMB 30.01105727 million.

The project is divided into two packages, and the bidder can only win one package at most. The maximum discount limit set for this project is 100%.